The trajectory of companies tied to iconic drugs like Viagra presents a nuanced investment picture. While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the loss of exclusivity in key markets has introduced substantial volatility. Investors are now grappling with the effect of generic competi